The landscape of dementia analysis has advanced significantly with the arrival of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-based mostly assessments which will detect Alzheimer's pathology years prior to signs emerge. Even though these technological advancements characterize remarkable development in understanding neurod